ACADIA Pharmaceuticals logo

ACADIA Pharmaceuticals Funding & Investors

Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

acadia-pharm.com

Total Amount Raised: $811,734,976

ACADIA Pharmaceuticals Funding Rounds

  • Post Ipo Equity

    $287,500,000

  • Post Ipo Equity

    $316,249,997

  • Post Ipo Equity

    $86,385,000

  • Grant

    $2,400,000

    Grant Investors

    National Institute of Neurological Disorders and Stroke (NINDS)
  • Post Ipo Equity

    $15,000,000

    Post Ipo Equity Investors

    Venrock
    NEA - New Enterprise Associates
  • Post Ipo Equity

    $20,000,000

    Post Ipo Equity Investors

    Nomura International
    Oxford Bioscience Partners
  • Post Ipo Equity

    $10,000,000

    Post Ipo Equity Investors

    Oxford Bioscience Partners
  • Series F

    $25,000,000

    Series F Investors

    Oxford Bioscience Partners
    OrbiMed Advisors
    LD Pensions
    Tekla Capital Management
    ABN AMRO Fund
    Federated Hermes
    Forbion Capital Partners
  • Debt Financing

    $22,000,000

    Debt Financing Investors

    Tekla World Healthcare Fund
    The Kaufman Fund
    DKA Capital
    Pacific Rim Ventures
    OrbiMed Advisors
  • Series D

    $10,700,000

    Series D Investors

    LD Pensions
    DKA Capital
  • Series B

    $3,000,000

    Series B Investors

    BankInvest
    LD Pensions
    DKA Capital
  • Debt Financing

    $7,500,000

    Debt Financing Investors

    Vækstfonden
  • Series A

    $6,000,000

    Series A Investors

    BankInvest
    LD Pensions
    DKA Capital
  • IPO

    Unknown

Funding info provided by Diffbot.